Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

Let’s dive in. Semaglutide is in a class called glucagon-like peptide-1 (GLP-1) receptor agonists. It works by mimicking GLP-1, a hormone the intestines naturally make. GLP-1 plays a key role in ...

Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.

A 2022 study found that people who stopped taking semaglutide and making lifestyle changes for 1 year regained two-thirds of the weight they had lost. For the best weight loss results, try ...

The drug — the brand name for the GLP-1 agonist semaglutide — “significantly reduced weekly alcohol craving,” according to a study published Wednesday, Feb. 12, in the Journal of the ...

A clinical trial shows that people who were considered by medical researchers to report signs of alcohol use disorder drank significantly less after taking semaglutide for two months, compared to ...

"Adherence improves when treatment integrates easily into patients’ lives," explains Adam McBride, Eden’s CEO. Eden’s digital ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder (AUD) reduce the amount they drink – pointing to yet another potential use ...

Semaglutide prescription initiation predictors included female sex and use of antidepressants among patients with obesity without diabetes.

“The first clinical trial testing the impact of an older GLP-1 receptor agonist on alcohol use in humans was inconclusive,” said Klein. “However, as prescription of semaglutide and similar ...